PHGDH and neuroblastoma: Similarly, Xia et al. recently reported that treating SK-N-AS and SH-SY5Y neuroblastoma cell lines, both with low-level PHGDH expression, with 10 μM NCT-503 reduced proliferation by up to 20% compared to controls.3